Literature DB >> 16298076

Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke.

L H Shen1, Y Li, J Chen, J Zhang, P Vanguri, J Borneman, M Chopp.   

Abstract

The present study investigates the induction of axon and myelin remodeling as a possible mechanism by which treatment of stroke with bone marrow stromal cells improves neurological functional recovery. Adult male Wistar rats were subjected to 2 h of middle cerebral artery occlusion, followed by an injection of 2 x 10(6) rat bone marrow stromal cells or phosphate-buffered saline into the internal carotid artery 24 h later. Animals were killed at 28 days after stroke. Functional tests, histo- and immunohistochemical staining were performed. Significant functional recovery was found after bone marrow stromal cell administration in all the three tests performed (modified neurological severity score, adhesive-removal and corner tests). Bone marrow stromal cell treatment markedly increased vessel sprouting, synaptophysin expression and NG2 positive cell numbers and density in the cortical peri-infarct area. In bone marrow stromal cell-treated rats, the number of Ki-67 positive proliferating cells and oligodendrocyte precursor cells in the corpus callosum increased significantly in concert with the enhancement of the areas of the corpus callosum in both hemispheres. These results suggest that bone marrow stromal cells facilitate axonal sprouting and remyelination in the cortical ischemic boundary zone and corpus callosum, which may underlie neurological functional improvement caused by bone marrow stromal cell treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16298076     DOI: 10.1016/j.neuroscience.2005.08.092

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  114 in total

1.  Bone marrow stromal cells produce long-term pain relief in rat models of persistent pain.

Authors:  Wei Guo; Hu Wang; Shiping Zou; Ming Gu; Mineo Watanabe; Feng Wei; Ronald Dubner; George T-J Huang; Ke Ren
Journal:  Stem Cells       Date:  2011-08       Impact factor: 6.277

Review 2.  Stem cell therapy for cerebral ischemia: from basic science to clinical applications.

Authors:  Koji Abe; Toru Yamashita; Shunya Takizawa; Satoshi Kuroda; Hiroyuki Kinouchi; Nobutaka Kawahara
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-18       Impact factor: 6.200

3.  Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke.

Authors:  D C Morris; M Chopp; L Zhang; M Lu; Z G Zhang
Journal:  Neuroscience       Date:  2010-08-25       Impact factor: 3.590

4.  Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia.

Authors:  Arjun V Pendharkar; Josh Y Chua; Robert H Andres; Nancy Wang; Xavier Gaeta; Hui Wang; Abhijit De; Raymond Choi; Shawn Chen; Brian K Rutt; Sanjiv S Gambhir; Raphael Guzman
Journal:  Stroke       Date:  2010-07-08       Impact factor: 7.914

Review 5.  Cell-based therapy for stroke.

Authors:  Yu Luo
Journal:  J Neural Transm (Vienna)       Date:  2010-10-14       Impact factor: 3.575

6.  AAV-mediated targeting of gene expression to the peri-infarct region in rat cortical stroke model.

Authors:  Kert Mätlik; Usama Abo-Ramadan; Brandon K Harvey; Urmas Arumäe; Mikko Airavaara
Journal:  J Neurosci Methods       Date:  2014-08-23       Impact factor: 2.390

7.  Intravascular stem cell transplantation for stroke.

Authors:  Angela M Auriat; Sahar Rosenblum; Tenille N Smith; Raphael Guzman
Journal:  Transl Stroke Res       Date:  2011-08-04       Impact factor: 6.829

Review 8.  Stem Cell-Based Immunomodulation After Stroke: Effects on Brain Repair Processes.

Authors:  Marieke C S Boshuizen; Gary K Steinberg
Journal:  Stroke       Date:  2018-05-03       Impact factor: 7.914

Review 9.  Bone marrow stromal cells as a therapeutic treatment for ischemic stroke.

Authors:  Zizhen Yang; Lei Zhu; Fangqin Li; Jing Wang; Huan Wan; Yujun Pan
Journal:  Neurosci Bull       Date:  2014-05-10       Impact factor: 5.203

10.  Regulation of serum response factor by miRNA-200 and miRNA-9 modulates oligodendrocyte progenitor cell differentiation.

Authors:  Benjamin Buller; Michael Chopp; Yuji Ueno; Li Zhang; Rui Lan Zhang; Daniel Morris; Yi Zhang; Zheng Gang Zhang
Journal:  Glia       Date:  2012-08-20       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.